meta_pixel
Tapesearch Logo
Log in
What Next | Daily News and Analysis

Big Pharma’s Bet on Psychedelics

What Next | Daily News and Analysis

Slate Podcasts

News, Daily News, News Commentary

4.32.4K Ratings

🗓️ 14 August 2022

⏱️ 27 minutes

🧾️ Download transcript

Summary

The psychedelic renaissance is here. But not everyone’s on board.

Guest: John Semley

Host: Sonari Glinton


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

This episode is brought to you by Best Buy. This year let Best Buy be your holiday

0:05.3

height partner. Whether you're searching for exciting gifts, trying to snag the hottest

0:09.3

holiday deals or looking for ways to simplify the giving and receiving experience, Best Buy is

0:14.7

here to help. Best Buy has the best assortment of impactful tech gifts, along with fast and free

0:20.9

fulfillment options and great deals all season long. Maybe you're looking for an air-fire to help

0:26.9

the aspiring foodie in your life unlock new recipes, or a new phone or camera for an aspiring

0:32.6

filmmaker who's turning their passion into a side gig. Or you might be on the hunt for a new

0:37.8

smartwatch to support a friend's wellness journey. No matter what you're looking for, Best Buy is your

0:43.2

gifting destination for everyone on your list. And Best Buy makes it easy to get your gifts how and

0:49.4

when you need them with free next day delivery on thousands of items, as well as same day delivery

0:54.7

and in-store pickup options. Shop great deals on gifts now at Best Buy.

1:07.9

Psychedelic

1:11.3

The very word makes me think, paisley, tie-dye, taking trips and getting high. But the idea of

1:18.6

getting magic mushrooms from real medical doctors? Well a few decades ago if you told me that I would

1:24.3

ask you, what are you smoking? The current reality, psychedelic drugs are still classified as

1:30.4

schedule one drugs. Schedule one drugs or drugs with no current, accepted medical use and a high

1:37.8

potential for abuse. But as regulations around these drugs are beginning to loosen, they're becoming

1:44.0

accepted treatments for a host of mental health issues. My real focus is on transforming mental

1:49.7

health care and that's something that really needs to happen for lots of people. That's George

1:54.9

Goldsmith. He's the CEO of Compass Pathways. It's a biotech company that's been investing money

2:01.0

in research on psychedelics. The goal to cash in on the potential benefits psychedelics

2:07.1

that have for mental health. Compass is one of these major biofarm players that has entered the scene

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Slate Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Slate Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.